Cargando…
The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention
BACKGROUND: Antiplatelet and anticoagulant therapy are commonly used before, during and after peripheral arterial endovascular intervention. This survey aimed to establish antiplatelet and anticoagulant choice for peripheral arterial endovascular intervention in contemporary clinical practice. METHO...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966346/ https://www.ncbi.nlm.nih.gov/pubmed/32026103 http://dx.doi.org/10.1186/s42155-019-0079-8 |
_version_ | 1783488716969345024 |
---|---|
author | Wong, Kitty H. F. Bosanquet, Dave C. Ambler, Graeme K. Qureshi, Mahim I. Hinchliffe, Robert J. Twine, Christopher P. |
author_facet | Wong, Kitty H. F. Bosanquet, Dave C. Ambler, Graeme K. Qureshi, Mahim I. Hinchliffe, Robert J. Twine, Christopher P. |
author_sort | Wong, Kitty H. F. |
collection | PubMed |
description | BACKGROUND: Antiplatelet and anticoagulant therapy are commonly used before, during and after peripheral arterial endovascular intervention. This survey aimed to establish antiplatelet and anticoagulant choice for peripheral arterial endovascular intervention in contemporary clinical practice. METHODS: Pilot-tested questionnaire distributed via collaborative research networks. RESULTS: One hundred and sixty-two complete responses were collected from responders in 22 countries, predominantly the UK (48%) and the rest of the European Union (44%). Antiplatelet monotherapy was the most common choice pre-procedurally (62%). In the UK, there was no difference between dual and single antiplatelet therapy use post procedure (50% vs. 37% p = 0.107). However, a significant majority of EU respondents used dual therapy (68% vs. 20% p < 0.001). There was variation in choice of antiplatelet therapy by the device used and the anatomical location of the intervention artery. The majority (82%) of respondents believed there was insufficient evidence to guide antithrombotic therapy after peripheral endovascular intervention and most (92%) would support a randomised trial. CONCLUSIONS: There is widespread variation in the use of antiplatelet therapy, especially post peripheral arterial endovascular intervention. Clinicians would support the development of a randomised trial comparing dual antiplatelet therapy with monotherapy. |
format | Online Article Text |
id | pubmed-6966346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-69663462020-02-04 The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention Wong, Kitty H. F. Bosanquet, Dave C. Ambler, Graeme K. Qureshi, Mahim I. Hinchliffe, Robert J. Twine, Christopher P. CVIR Endovasc Short Communication BACKGROUND: Antiplatelet and anticoagulant therapy are commonly used before, during and after peripheral arterial endovascular intervention. This survey aimed to establish antiplatelet and anticoagulant choice for peripheral arterial endovascular intervention in contemporary clinical practice. METHODS: Pilot-tested questionnaire distributed via collaborative research networks. RESULTS: One hundred and sixty-two complete responses were collected from responders in 22 countries, predominantly the UK (48%) and the rest of the European Union (44%). Antiplatelet monotherapy was the most common choice pre-procedurally (62%). In the UK, there was no difference between dual and single antiplatelet therapy use post procedure (50% vs. 37% p = 0.107). However, a significant majority of EU respondents used dual therapy (68% vs. 20% p < 0.001). There was variation in choice of antiplatelet therapy by the device used and the anatomical location of the intervention artery. The majority (82%) of respondents believed there was insufficient evidence to guide antithrombotic therapy after peripheral endovascular intervention and most (92%) would support a randomised trial. CONCLUSIONS: There is widespread variation in the use of antiplatelet therapy, especially post peripheral arterial endovascular intervention. Clinicians would support the development of a randomised trial comparing dual antiplatelet therapy with monotherapy. Springer International Publishing 2019-11-12 /pmc/articles/PMC6966346/ /pubmed/32026103 http://dx.doi.org/10.1186/s42155-019-0079-8 Text en © The Author(s) 2020, corrected publication 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Short Communication Wong, Kitty H. F. Bosanquet, Dave C. Ambler, Graeme K. Qureshi, Mahim I. Hinchliffe, Robert J. Twine, Christopher P. The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title | The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title_full | The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title_fullStr | The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title_full_unstemmed | The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title_short | The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
title_sort | clear (considering leading experts’ antithrombotic regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966346/ https://www.ncbi.nlm.nih.gov/pubmed/32026103 http://dx.doi.org/10.1186/s42155-019-0079-8 |
work_keys_str_mv | AT wongkittyhf theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT bosanquetdavec theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT amblergraemek theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT qureshimahimi theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT hinchlifferobertj theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT twinechristopherp theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT theclearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT wongkittyhf clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT bosanquetdavec clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT amblergraemek clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT qureshimahimi clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT hinchlifferobertj clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT twinechristopherp clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention AT clearconsideringleadingexpertsantithromboticregimesaroundperipheralangioplastysurveyaninternationalperspectiveonantiplateletandanticoagulantpracticeforperipheralarterialendovascularintervention |